Read what clients have to say

Case Histories

A research study for Astra Zeneca, to evaluate a certain anti-hypertensive, required 16 completed subjects to be enrolled in two months.

	Lifespan completed the entire study within 5 weeks.
	Lifespan completed the entire case report forms simultaneously with the study's conclusion.
	Lifespan maintained a retention rate of 99%, the lowest site dropout rate in the study.

Sirex, a Clinical Research Organization (CRO), was engaged in an osteoarthritis study for Roberts Pharmaceutical, requiring 16 completed subjects with osteoarthritis of the knee or hip. It was a 4-week randomized double-blind, placebo-controlled study in two phases, with an open-label extension phase of 6 months.

	Lifespan enrolled 41 subjects in 6 months.
	CRFs were finished at the completion of the study.
	Total number supplied by Lifespan exceeded contractual obligation.